Treede RD, Rief W, Barke A, et al. A classification of chronic pain for the ICD-11. Pain. 2019;160(1):19-27.

World Health Organization. WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents. Geneva: WHO; 2018.

National Comprehensive Cancer Network. Adult Cancer Pain. Version 2.2025.

Paice JA, Bohlke K, Barton D, et al. Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline. J Clin Oncol. 2023;41(4):914-930.

Fallon M, Giusti R, Aielli F, et al. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29(Suppl 4):iv166-iv191.

van den Beuken-van Everdingen MHJ, Hochstenbach LMJ, Joosten EAJ, Tjan-Heijnen VCG, Janssen DJA. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage. 2016;51(6):1070-1090.e9.

Snijders RAH, Brom L, Theunissen M, van den Beuken-van Everdingen MHJ. Update on prevalence of pain in cancer patients 2022: a systematic literature review and meta-analysis. Cancers (Basel). 2023;15(3):591.

Knaul FM, Farmer PE, Krakauer EL, et al. Alleviating the access abyss in palliative care and pain relief: The Lancet Commission report. Lancet. 2018;391(10128):1391-1454.

Portenoy RK, Hagen NA. Breakthrough pain: definition, prevalence and characteristics. Pain. 1990;41(3):273-281.

Hurwitz MD, Ghanouni P, Kanaev SV, et al. Magnetic resonance–guided focused ultrasound for painful bone metastases: Phase III trial. J Natl Cancer Inst. 2014;106(5):dju082.

Stopeck AT, Lipton A, Body JJ, et al. Denosumab vs zoledronic acid for bone metastases in breast cancer. J Clin Oncol. 2010;28(35):5132-5139.

Fizazi K, Carducci M, Smith M, et al. Denosumab vs zoledronic acid in castration-resistant prostate cancer. Lancet. 2011;377(9768):813-822.

Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994;23(2):129-138.

Smith EML, Pang H, Cirrincione C, et al. Duloxetine for chemotherapy-induced peripheral neuropathy: RCT. JAMA. 2013;309(13):1359-1367.

Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain: systematic review & meta-analysis. Lancet Neurol. 2015;14(2):162-173.

Derry S, Wiffen PJ, Moore RA. Oral NSAIDs for cancer pain in adults. Cochrane Database Syst Rev. 2017;7:CD012638.

Wiffen PJ, Derry S, Moore RA. Paracetamol (acetaminophen) for cancer pain. Cochrane Database Syst Rev. 2017;7:CD012637.

Bell RF, Eccleston C, Kalso EA. Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev. 2017;6:CD003351.

Hurlow A, Bennett MI, Robb KA, Johnson MI, Simpson KH, Oxberry SG. TENS for cancer pain. Cochrane Database Syst Rev. 2012;3:CD006276.

World Health Organization. Persisting Pain in Children with Medical Illnesses. Geneva: WHO; 2012.

U.S. Food & Drug Administration. FDA Drug Safety Communication: Codeine and Tramadol Restrictions in Children. 2017.

World Health Organization. Guidelines on the Management of Chronic Pain in Children. Geneva: WHO; 2020.

Cherny NI, Radbruch L; Board of the European Association for Palliative Care. EAPC framework for sedation. Palliat Med. 2009;23(7):581-593.

Surges SM, Ostgathe C, Radbruch L, et al. Revised EAPC framework for palliative sedation: Delphi study. Palliat Med. 2024;38(2):213-228.

Dowell D, Ragan KR, Jones CM, et al. CDC Clinical Practice Guideline for Prescribing Opioids — United States, 2022. MMWR Recomm Rep. 2022;71(3):1-95.

National Cancer Institute. Cancer Pain (PDQ®) – Health Professional Version. Updated Apr 24, 2025.



